Methods for treating hypersomnia
US10688103B2 · kind B2 · utility
0Cited by
3References
29Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 14, 2015 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Jun 9, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods, formulations and dosing regimens for treating hypersomnia in a subject. For instance, methods provided herein comprise administering a GABAA chloride channel blocker. In certain embodiments, the GABAA chloride channel blocker is pentylenetetrazol (PTZ).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.